Surgical and non-surgical management of secondary and primary hyperparathyroidism. Systematic review [Manejo quirúrgico y no quirúrgico de la hiperparatiroidismo secundario y primario. Revisión sistemática]
DOI:
https://doi.org/10.62574/hrqhjj63Keywords:
hyperparathyroidism secondary, hyperparathyroidism, hyperparathyroidism primaryAbstract
Objective: to analyse the surgical and non-surgical management of secondary and primary hyperparathyroidism. Method: Systematic review. Results and conclusion: The management of both primary and secondary hyperparathyroidism should be based on a comprehensive and personalised evaluation that considers the severity of the disease, the patient's comorbidities and the available therapeutic options. Parathyroidectomy is consolidated as an effective intervention in serious cases, offering significant benefits in metabolic control and the prevention of complications, although non-surgical strategies, such as the use of cinacalcet, represent viable alternatives in patients not suitable for surgery, technological advances, such as microwave ablation and improved surgical techniques, promise to optimise clinical results.
Downloads
References
Cheng J, Lv Y, Zhang L, Liu Y. Construction and validation of a predictive model for hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism. Front Endocrinol (Lausanne). 2022;13:1040264. Published 2022 Nov 30. doi:10.3389/fendo.2022.1040264
Wang AY, Lo WK, Cheung SC, Tang TK, Yau YY, Lang BH. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial. Nephrol Dial Transplant. 2023;38(8):1823-1835. doi:10.1093/ndt/gfad043
Wang AY, Tang TK, Yau YY, Lo WK. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial. Am J Kidney Dis. 2024;83(4):456-466.e1. doi:10.1053/j.ajkd.2023.10.007
Kang J, Li S, Su J, et al. Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial. Medicine (Baltimore). 2024;103(52):e40917. doi:10.1097/MD.0000000000040917
Hu S, Shu T, Xu S, Ju X, Wang S, Ma L. Ultrasound-guided bilateral superficial cervical plexus block enhances the quality of recovery of uremia patients with secondary hyperparathyroidism following parathyroidectomy: a randomized controlled trial. BMC Anesthesiol. 2021;21(1):228. Published 2021 Sep 18. doi:10.1186/s12871-021-01448-w
Zhao J, Qian L, Teng C, et al. A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism. Int J Hyperthermia. 2021;38(1):1558-1565. doi:10.1080/02656736.2021.1904153
Pereira GMD, Liao M, Arap SS, et al. Parathyroidectomy reduces the costs of medication in patients with secondary hyperparathyroidism. Clinics (Sao Paulo). 2024;79:100484. Published 2024 Sep 15. doi:10.1016/j.clinsp.2024.100484
Moreno P, Coloma A, Torregrosa JV, et al. Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism. Clin Transplant. 2020;34(8):e13988. doi:10.1111/ctr.13988
Heck A, Pretorius M, Lundstam K, et al. No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial. Eur J Endocrinol. 2024;191(3):354-360. doi:10.1093/ejendo/lvae109
Ding C, Guo Y, Mo Q, Ma J. Prediction Model of Postoperative Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism Based on Logistic Regression and XGBoost Algorithm. Comput Math Methods Med. 2022;2022:8752826. Published 2022 Jul 25. doi:10.1155/2022/8752826
Dudar I, Shifris I, Dudar S, Kulish V. Current therapeutic options for the treatment of secondary hyperparathyroidism in end-stage renal disease patients treated with hemodialysis: a 12-month comparative study. Pol Merkur Lekarski. 2022;50(299):294-298.
Frey S, Bannani S, Caillard C, et al. Parathyroid near-infrared autofluorescence use for parathyroidectomy in mild primary hyperparathyroidism: Results from a randomized monocentric trial. Surgery. 2025;177:108878. doi:10.1016/j.surg.2024.05.062
Chen J, Feng J, Zhou Q, et al. Intraoperative 99mTc-MIBI-Guided Parathyroidectomy Improves Curative Effect of Parathyroidectomy, Bone Metabolism, and Bone Mineral Density. Am Surg. 2021;87(3):463-472. doi:10.1177/0003134820951467
Bolland MJ, Grey A. Nonoperative Management of Mild Primary Hyperparathyroidism: A Reasonable, Evidence-Based Option. Ann Intern Med. 2022;175(6):899-900. doi:10.7326/M22-0922
Pretorius M, Lundstam K, Heck A, et al. Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation. Ann Intern Med. 2022;175(6):812-819. doi:10.7326/M21-4416
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Alex Ramón Valencia-Herrera, Liliana Katherine Sailema López, Génesis Alexandra Zúñiga Cárdenas, Alan Enoc Tapia Flores
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
